Denali Therapeutics Inc. Profile Avatar - Palmy Investing

Denali Therapeutics Inc.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151…
Biotechnology
US, South San Francisco [HQ]
Major Shareholders · Outstanding & Floating · Short Interest

Share Analysis

Breakdown
Short
Fail To Deliver
Not available for DNLI
Shorts Over Time
Not available for DNLI
Latest Settlement
Settlement Date n/a
Short Volume $n/a
Change n/a
Short Float n/a
Change n/a
Days to Cover n/a
Change n/a